Abstract:The advent of high throughput technologies has revealed that mammalian genomes are pervasively transcribed, most for long noncoding RNAs (lncRNAs, at least 200 nt long). Thousands of lncRNAs from intergenic regions (large intergenic noncoding RNA, lincRNA) have been uncovered by massive deep sequencing from the repertoire of polyadenylated (poly(A)+) RNAs, together with multiple chromatin landscapes. These lncRNAs are messenger RNA (mRNA)-like, with linear signatures of 5′ mG caps and 3′ poly(A)+ tails. Unexpectedly, mammalian transcriptomes are even more complex with the expression of RNAs without polyadenylated tails (poly(A)– RNAs) [1], leading to the identification of new lncRNA formats, such as circular RNAs. Due to the covalently close structure and without 3′ poly(A) tails, circular RNAs failed to be analyzed in most transcriptome analyses mainly for polyadenylated RNAs. By taking advantage of deep sequencing from nonpolyadenylated RNA population [1], thousands of circular RNAs were identified to be widely expressed in human cell lines. There are at least two different types of circular RNAs processed from pre-RNA splicing: one type is derived from spliced introns (circular intronic RNAs) [2] and the other type is from back-spliced exons (exonic circular RNAs) [3]. Circular intronic RNAs (ciRNAs) are produced from introns that fail to be debranched after splicing, but covalently circularized with 2′,5′-phosphodiester bond between a splice donor site and a branch point site. The formation of ciRNAs can be reconstituted in expression vectors with the requirement of consensus motifs flanking 2′,5′-phosphodiester bonds. Importantly, ciRNAs were shown to play an important cis-regulatory role in local gene expression [2]. Exonic circular RNAs (circRNAs) are produced from back-spliced circularization [3]. Unlike (normal) RNA splicing that joins an upstream splice donor site with a downstream splice acceptor site, leading to a linear RNA transcript (Figure 1A), back splicing joins a downstream splice donor site reversely with an upstream splice acceptor site, yielding a circular RNA transcript with 3′,5′-phosphodiester bond at the joint site (Figure 1B). In last decades, only a handful of circRNAs were identified and indicated as byproducts of splicing errors with no function. Until recently, the genome-wide profiling of

Utility of oligonucleotide in upregulating circular RNA production in a cellular model

CircPro: an Integrated Tool for the Identification of Circrnas with Protein-Coding Potential.

Circular RNA: an emerging key player in RNA world.

Efficient circularization of protein-encoding RNAs via a novel cis -splicing system

Engineering circular RNA regulators to specifically promote circular RNA production

Engineering circular RNA for molecular and metabolic reprogramming

Engineering circular RNA for enhanced protein production

An intriguing RNA species—perspectives of circularized RNA

Circular Sirnas for Reducing Off-Target Effects and Enhancing Long-Term Gene Silencing in Cells and Mice

Chemical circularization of in vitro transcribed RNA opens new avenues for circular mRNA design

A Simple and Efficient One-Step Synthesis System for Flexible Production of Circular RNA in E. coli

A Highly Efficient Strategy for Overexpressing circRNAs.

Tactics targeting circular mRNA biosynthesis

Modulating miRNA binding sites within circRNA for enhanced translation efficiency

Analytical Methods and Platforms for circRNA Vector Engineering to Improve Circularization Efficiency

Circular mRNA: A novel therapeutic agent

Circular RNA: Biosynthesis in Vitro.

CircRNA-based Therapeutics: Current Opinions and Clinical Potential

Robust genome and cell engineering via in vitro and in situ circularized RNAs

The Biogenesis, Functions, and Challenges of Circular RNAs

Competition of RNA Splicing: Line in or Circle Up